182 related articles for article (PubMed ID: 204635)
21. Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue.
Price B; Pyne NJ; Houslay MD
Biochem Pharmacol; 1987 Dec; 36(23):4047-54. PubMed ID: 2825712
[TBL] [Abstract][Full Text] [Related]
22. [Two forms of cyclic nucleotide phosphodiesterase and Ca-dependent protein regulator from rabbit skeletal muscles].
Lazarevich VG; Men'shikov MIu; Tkachuk VA
Biokhimiia; 1979 Oct; 44(10):1842-51. PubMed ID: 228768
[TBL] [Abstract][Full Text] [Related]
23. Regulation of cyclic nucleotide phosphodiesterase activity in human lung fibroblasts.
Duttagupta C; Rifas L; Makman MH
Biochim Biophys Acta; 1978 Apr; 523(2):385-94. PubMed ID: 207333
[TBL] [Abstract][Full Text] [Related]
24. Platelet cyclic 3':5'-nucleotide phosphodiesterase released by thrombin and calcium ionophore.
Hidaka H; Asano T
J Biol Chem; 1976 Dec; 251(23):7508-16. PubMed ID: 187590
[TBL] [Abstract][Full Text] [Related]
25. Studies on cyclic nucleotide metabolism in Tetrahymena pyriformis: partial characterization of cyclic AMP- and cyclic GMP-dependent phosphodiesterases.
Kudo S; Nakazawa K; Nozawa Y
J Protozool; 1980 Aug; 27(3):342-5. PubMed ID: 6109021
[TBL] [Abstract][Full Text] [Related]
26. A separate phosphodiesterase for the hydrolysis of cyclic guanosine 3',5'-monophosphate in growing Dictyostelium discoideum amoebae.
Dicou E; Brachet P
Eur J Biochem; 1980 Aug; 109(2):507-14. PubMed ID: 6250845
[TBL] [Abstract][Full Text] [Related]
27. The metabolism of cyclic nucleotides in the guinea-pig pancreas. Cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase.
Methven P; Lemon M; Bhoola K
Biochem J; 1980 Feb; 186(2):491-8. PubMed ID: 6246887
[TBL] [Abstract][Full Text] [Related]
28. Regulation of cyclic nucleotide phosphodiesterase activity.
Vaughan M; Danello MA; Manganiello VC; Strewler GJ
Adv Cyclic Nucleotide Res; 1981; 14():263-71. PubMed ID: 6169258
[No Abstract] [Full Text] [Related]
29. Proteolytic activation of Ca2+-dependent cyclic nucleotide phosphodiesterase from Escherichia coli.
Iwasa Y
Horm Metab Res; 1981 Jul; 13(7):414-5. PubMed ID: 6268507
[TBL] [Abstract][Full Text] [Related]
30. Evidence for convertible forms of soluble uterine cyclic nucleotide phosphodiesterase.
Strada SJ; Epstein PM; Gardner EA; Thompson WJ; Stancel GM
Biochim Biophys Acta; 1981 Sep; 661(1):12-20. PubMed ID: 6271215
[TBL] [Abstract][Full Text] [Related]
31. Purification and characterization of high-affinity cyclic adenosine monophosphate phosphodiesterase from dog kidney.
Thompson WJ; Epstein PM; Strada SJ
Biochemistry; 1979 Nov; 18(23):5228-37. PubMed ID: 227451
[No Abstract] [Full Text] [Related]
32. Cyclic nucleotide hydrolysis in the thyroid gland. General properties and key role in the interrelations between concentrations of adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate.
Erneux C; Van Sande J; Dumont JE; Boeynaems JM
Eur J Biochem; 1977 Jan; 72(1):137-47. PubMed ID: 12974
[TBL] [Abstract][Full Text] [Related]
33. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells.
Lugnier C; Schini VB
Biochem Pharmacol; 1990 Jan; 39(1):75-84. PubMed ID: 2153383
[TBL] [Abstract][Full Text] [Related]
34. Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase.
Grant PG; Colman RW
Biochemistry; 1984 Apr; 23(8):1801-7. PubMed ID: 6326810
[TBL] [Abstract][Full Text] [Related]
35. [Separation and investigation of the regulatory properties of two forms of cyclic nucleotide phosphodiesterase from rabbit heart--sensitive and insensitive to Ca-dependent regulator protein].
Tkachuk VA; Lazarevich VG; Men'shikov MIu; Severin SE
Biokhimiia; 1978 Sep; 43(9):1622-30. PubMed ID: 214170
[TBL] [Abstract][Full Text] [Related]
36. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics.
Weishaar RE; Quade MM; Schenden JA; Evans DB
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(6):551-64. PubMed ID: 3003170
[TBL] [Abstract][Full Text] [Related]
37. Characterization of various horse thyroid forms of cyclic-nucleotide phosphodiesterase [proceedings].
Erneux C; Couchie D
Arch Int Physiol Biochim; 1979 May; 87(2):408-10. PubMed ID: 92956
[No Abstract] [Full Text] [Related]
38. Human blood platelet 3': 5'-cyclic nucleotide phosphodiesterase. Isolation of low-Km and high-Km phosphodiesterase.
Hidaka H; Asano T
Biochim Biophys Acta; 1976 Apr; 429(2):485-97. PubMed ID: 177073
[TBL] [Abstract][Full Text] [Related]
39. Effect of somatostatin and dopaminergic agents on bovine pituitary phosphodiesterase activity.
Nagasaka A; Hidaka H; Nakagawa H; Nakai A; Ohyama T; Aono T; Masunaga R; Iwase K
Neuroendocrinology; 1986; 43(3):410-5. PubMed ID: 2874515
[TBL] [Abstract][Full Text] [Related]
40. [Cyclic AMP-specific nucleotide phosphodiesterase from the insoluble fraction of the human brain].
Kireeva NN; Bobruskin ID; Severin SE
Biokhimiia; 1995 May; 60(5):694-708. PubMed ID: 7662796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
